Pfizer

Pfizer’s Palbociclib (PD-0332991) Receives FDA Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer

Pfizer’s Palbociclib (PD-0332991) Receives FDA Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer

Yahoo

Where Is Pfizer Heading With The Patent Cliff?

Where Is Pfizer Heading With The Patent Cliff?

Seeking Alpha

U.S. drugmakers Pfizer, J&J top reputation ranks in Germany, Italy

U.S. drugmakers Pfizer, J&J top reputation ranks in Germany, Italy

Fierce Pharma

Can Bristol-Myers Squibb Compete In Immuno-Oncology?

Can Bristol-Myers Squibb Compete In Immuno-Oncology?

Seeking Alpha

This Week in Biotech

This Week in Biotech

Motley Fool

4 Healthcare Stock Stories for Weekend Investment Wellness

4 Healthcare Stock Stories for Weekend Investment Wellness

Wall Street Cheat Street

Pfizer's Oncology Division Gets A Boost With European Approval For Bosulif

Pfizer's Oncology Division Gets A Boost With European Approval For Bosulif

Seeking Alpha

A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation

A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation

Seeking Alpha

3 Ways Big Pharma Is Seizing This Rare Opportunity

3 Ways Big Pharma Is Seizing This Rare Opportunity

Motley Fool

Can New Psoriasis Drugs Scratch Investors' Itch?

Can New Psoriasis Drugs Scratch Investors' Itch?

Investors.com